Parkside Financial Bank & Trust’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2K | Buy |
97
+38
| +64% | +$4.78K | ﹤0.01% | 1423 |
|
|
2025
Q1 | $6.53K | Buy |
59
+44
| +293% | +$4.87K | ﹤0.01% | 1557 |
|
|
2024
Q4 | $2.05K | Buy |
15
+13
| +650% | +$1.78K | ﹤0.01% | 1622 |
|
|
2024
Q3 | $231 | Hold |
2
| – | – | ﹤0.01% | 1985 |
|
|
2024
Q2 | $276 | Hold |
2
| – | – | ﹤0.01% | 1884 |
|
|
2024
Q1 | $276 | Hold |
2
| – | – | ﹤0.01% | 1866 |
|
|
2023
Q4 | $264 | Sell |
2
-3
| -60% | -$396 | ﹤0.01% | 1879 |
|
|
2023
Q3 | $563 | Buy |
+5
| New | +$563 | ﹤0.01% | 1904 |
|
|
2023
Q2 | – | Sell |
-11
| Closed | -$1.11K | – | 2073 |
|
|
2023
Q1 | $1.11K | Hold |
11
| – | – | ﹤0.01% | 1828 |
|
|
2022
Q4 | $1.31K | Buy |
+11
| New | +$1.31K | ﹤0.01% | 1792 |
|
|
2021
Q4 | – | Sell |
-15
| Closed | -$1K | – | 1880 |
|
|
2021
Q3 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 1687 |
|
|
2019
Q1 | – | Sell |
-171
| Closed | -$12K | – | 1609 |
|
|
2018
Q4 | $12K | Hold |
171
| – | – | ﹤0.01% | 707 |
|
|
2018
Q3 | $21K | Hold |
171
| – | – | 0.01% | 596 |
|
|
2018
Q2 | $17K | Hold |
171
| – | – | 0.01% | 626 |
|
|
2018
Q1 | $14K | Buy |
171
+31
| +22% | +$2.54K | 0.01% | 650 |
|
|
2017
Q4 | $11K | Buy |
+140
| New | +$11K | ﹤0.01% | 714 |
|